Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy
Julia ML Brotherton, John M Kaldor, Suzanne M Garland
Sexual Health | CSIRO PUBLISHING | Published : 2010
JMLB was an investigator on an investigator-driven study of HPV prevalence in Australia that received partial equal and unrestricted grant funding from CSL Ltd and GlaxoSmithKline (GSK). She was also an investigator on a serosurvey of HPV antibodies in Australia that received funding for the laboratory testing component from CSL Ltd.JMK is a co-investigator on a research project that has received support from Merck and CSL Ltd through the provision of the HPV vaccine (Gardasil).SMG has received advisory board fees and grant support from CSL and GSK, and lecture fees from Merck and GSK. She has received funding through her institution to conduct HPV vaccine studies for MSD and GSK. SMG is a member of the Merck Global Advisory Board as well as the Merck Scientific Advisory Committee for HPV prophylactic vaccines.